•  Driving research and developing potential therapeutic strategies for CFC syndrome.

•  Supporting families affected by MEK2 mutations worldwide.

•  Initiating collaborations with clinicians and research institutions to accelerate studies on MEK2 and other mutations causing CFC syndrome (Cardio-Facio-Cutaneous syndrome).

•  Integrating Polish patients with Rasopathies (a group of diseases that includes CFC syndrome).

•  Educating local authorities about ultra-rare diseases.

•  Engaging in public awareness campaigns and securing support from celebrities and national media.
•  Contributing to the development of rare disease legislation in Poland.

MEK2 Research Foundation

Org chart

Teams

Offices